Laboratory Facility
Microbiological assays
The VIDA Laboratory and Basic Science Division provides the scientific foundation for our research, combining advanced technologies with expert teams to deliver high-quality, policy-relevant data. Our laboratories support clinical trials and observational studies through cutting-edge immunological, molecular, and microbiological testing.
From sequencing and molecular serotyping to novel assay development and antimicrobial resistance diagnostics, our laboratory scientists generate evidence that guides vaccine development, public health strategies, and global scientific understanding.
Our work includes:
-
Developing and validating new laboratory methods to support emerging research needs.
-
Investigating the immunology of vaccines and host-pathogen interactions.
-
Tracking and characterising antimicrobial-resistant pathogens in both neonates and adults.
-
Supporting multinational collaborations with robust laboratory infrastructure and technical expertise.
Beyond discovery, VIDA’s laboratories are a platform for capacity building, equipping the next generation of African scientists with advanced skills and mentorship. By integrating basic science with clinical and field research, we ensure that every breakthrough is backed by rigorous, world-class laboratory evidence.
Technical Expertise
Immunoassays
Quantitative and qualitative assessments of:
- Serum and salivary IgA and IgG antibody levels: raised naturally or in a response to specific vaccine antigens.
- Cytokine profiling, interferon gamma release assays and other disease markers.
- Functional antibody assays.
Molecular Diagnostics
Nucleic acid based detection of specific bacterial and viral pathogens.
Microbiology Diagnostics
Identification, isolation as well as the biochemical and antimicrobial sensitivity testing of study specific bacterial isolates. Examples of the bacteria include (but is not limited to) Streptococcus pneumoniae, Streptococcus agalactiae, Haemophilus influenzae and Staphylococcus aureus.
